
Sign up to save your podcasts
Or
In this episode of Bulletproof Radio, my guest, Dr. Andrew Miller, is an internationally recognized expert in the interactions between the brain and immune system as they relate to stress and depression.
“Inflammaging is one of the hottest topics in immunology right now because we recognize that much of what drives the process of aging in the brain and much of what drives many of the illnesses that eventually do people in, are driven by inflammation,” he says. “So, we're talking cardiovascular disease, we're talking about diabetes, we're talking about cancer, we're talking about neurodegenerative disorders.” … “All the modern ills that we as a society are grappling with right now.”
Dr. Miller is the vice-chair of Research in the Department of Psychiatry and Behavioral Sciences and director of the Behavioral Immunology Program at Emory School of Medicine. His research focuses on the underlying mechanisms by which inflammation can cause depression in humans and non-human primates. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy for the treatment of depression.
Enjoy the show!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
4.6
68636,863 ratings
In this episode of Bulletproof Radio, my guest, Dr. Andrew Miller, is an internationally recognized expert in the interactions between the brain and immune system as they relate to stress and depression.
“Inflammaging is one of the hottest topics in immunology right now because we recognize that much of what drives the process of aging in the brain and much of what drives many of the illnesses that eventually do people in, are driven by inflammation,” he says. “So, we're talking cardiovascular disease, we're talking about diabetes, we're talking about cancer, we're talking about neurodegenerative disorders.” … “All the modern ills that we as a society are grappling with right now.”
Dr. Miller is the vice-chair of Research in the Department of Psychiatry and Behavioral Sciences and director of the Behavioral Immunology Program at Emory School of Medicine. His research focuses on the underlying mechanisms by which inflammation can cause depression in humans and non-human primates. Additionally, Dr. Miller and his group conducted the first clinical trial examining the efficacy of an immunotherapy for the treatment of depression.
Enjoy the show!
See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
5,013 Listeners
361 Listeners
4,571 Listeners
580 Listeners
679 Listeners
141 Listeners
176 Listeners
1,222 Listeners
381 Listeners
715 Listeners
4,831 Listeners
3,517 Listeners
9,349 Listeners
1,812 Listeners
1,200 Listeners
2,602 Listeners
1,757 Listeners
734 Listeners
278 Listeners
1,129 Listeners
2,968 Listeners